Characteristics | Total ARDS | Community-acquired ARDS | Hospital-acquired ARDS | ICU-acquired ARDS | p |
---|---|---|---|---|---|
(n = 296) | (n = 70) | (n = 83) | (n = 143) | ||
Age (years) | 63.0 ± 16.5 | 62.8 ± 19.9 | 62.3 ± 16.0 | 63.5 ± 15.2 | 0.855 |
Gender (male/female) | 198/98 | 47/23 | 50/33 | 101/42 | 0.278 |
BMI (kg/m2) | 23.6 ± 4.2 | 23.9 ± 3.9 | 23.6 ± 3.7 | 23.5 ± 4.6 | 0.811 |
PBW | 57 ± 10 | 56.8 ± 8.0 | 56.2 ± 10.5 | 57.6 ± 10.6 | 0.580 |
CCI | 3.4 ± 2.4 | 2.83 ± 2.2 | 3.63 ± 2.8 | 3.56 ± 2.2 | 0.068 |
APACHE II score | 25.1 ± 6.9 | 26.1 ± 6.6 | 24.5 ± 6.9 | 25.0 ± 7.2 | 0.339 |
SOFA score | 11.5 ± 3.8 | 10.7 ± 3.5 | 11.7 ± 4.0 | 11.8 ± 3.9 | 0.107 |
MOD score | 9.8 ± 3.4 | 9.3 ± 2.9 | 9.9 ± 3.6 | 10.0 ± 3.6 | 0.300 |
Lung injury score | 2.9 ± 0.5 | 3.1 ± 0.4 | 2.9 ± 0.5 | 3.0 ± 0.5 | 0.249 |
Tidal volume (ml/PBW) | 8.4 ± 2.0 | 8.1 ± 1.7 | 8.7 ± 1.9 | 8.3 ± 2.1 | 0.241 |
PEEP (cm H2O) | 10.2 ± 2.2 | 10.1 ± 2.0 | 9.8 ± 1.9 | 10.5 ± 2.5 | 0.078 |
Peak Paw (cm H2O) | 29.8 ± 5.9 | 30.0 ± 5.2 | 29.6 ± 5.3 | 29.8 ± 6.5 | 0.918 |
pH | 7.35 ± 0.11 | 7.33 ± 0.11 | 7.37 ± 0.12 | 7.35 ± 0.11 | 0.059 |
PaCO2 (mm Hg) | 45.0 ± 17.3 | 44.9 ± 13.7 | 41.4 ± 14.9 | 47.2 ± 19.8 | 0.053 |
FiO2 | 0.8 ± 0.2 | 0.81 ± 0.19 | 0.79 ± 0.22 | 0.77 ± 0.23 | 0.082 |
PaO2/FiO2 (mm Hg) | 129.1 ± 70.0 | 115.0 ± 66.4 | 132.3 ± 68.1 | 133.8 ± 72.3 |  |
Severity of ARDS | |||||
 Mild | 51(17.2 %) | 9(12.9 %) | 14(16.9 %) | 28(19.6 %) | 0.3383 |
 Moderate | 109(36.8 %) | 24(34.3 %) | 31(37.3 %) | 54(37.8 %) | 0.7677 |
 Severe | 136(46.0 %) | 37(52.9 %) | 38(45.8 %) | 61(42.7 %) | 0.6242 |
Cause of ARDS | |||||
 Pneumonia | 141 | 34(48.6 %) | 48(57.8 %) | 59(41.3 %) | 0.055 |
 Sepsis | 81 | 18(25.7 %) | 21(25.3 %) | 42(29.4 %) | 0.755 |
 Aspiration | 52 | 11(15.7 %) | 19(22.9 %) | 22(15.9 %) | 0.323 |
 Major surgery | 8 | 2(2.9 %) | 3(3.6 %) | 3(2.1 %) | 0.733 |
 Acute pancreatitis | 6 | 1(1.4 %) | 1(1.2 %) | 4(2.8 %) | 0.872 |
 Others | 8 | 2(2.9 %) | 2(2.4 %) | 4(2.8 %) | 1.000 |
Components of CCI | |||||
 Myocardial infarct | 10 | 1(1.4 %) | 3(3.6 %) | 6(4.2 %) | 0.570 |
 CHF | 29 | 8(11.4 %) | 9(10.8 %) | 12(8.4 %) | 0.729 |
 Peripheral vascular disease | 11 | 4(5.7 %) | 2(2.4 %) | 5(3.5 %) | 0.550 |
 Cerebrovascular disease | 91 | 25(35.7 %) | 24(28.9 %) | 42(29.4 %) | 0.562 |
 Dementia | 6 | 3(4.3 %) | 1(1.2 %) | 2(1.4 %) | 0.306 |
 Chronic pulmonary disease | 31 | 11(15.7 %) | 7(8.4 %) | 13(9.1 %) | 0.258 |
 Connective tissue disease | 1 | 0(0 %) | 1(1.2 %) | 0(0 %) | 0.276 |
 Ulcer disease | 47 | 6(8.6 %) | 13(15.7 %) | 28(19.6 %) | 0.118 |
 Mild liver disease | 12 | 1(1.4 %) | 3(3.6 %) | 8(5.6 %) | 0.341 |
 Diabetes without end organ damage | 80 | 21(30 %) | 17(20.5 %) | 42(29.4 %) | 0.284 |
 Hemiplegia or paraplegia | 16 | 5(7.1 %) | 3(3.6 %) | 8(5.6 %) | 0.542 |
 Moderate to severe renal disease | 88 | 25(35.7 %) | 18(21.7 %) | 45(31.5 %) | 0.137 |
 Diabetes with end organ damage | 3 | 0(0.0 %) | 1(1.2 %) | 2(1.4 %) | 0.472 |
 Any tumor without metastasis | 44 | 8(11.4 %) | 15(18.1 % ) | 21(14.7 %) | 0.514 |
 Leukemia | 2 | 0(0 %) | 0(0 %) | 2(1.4 %) | 0.341 |
 Lymphoma | 4 | 0(0 %) | 1(1.2 %) | 3(2.1 %) | 0.616 |
 Moderate to severe liver disease | 47 | 0(0.0 %) | 16(19.3 %) | 31(21.7 %) | 0.000* |
 Metastatic solid tumor | 41 | 5(7.1 %) | 17(20.5 %) | 19(13.3 %) | 0.057 |
 AIDS | 2 | 2(2.9 %) | 0(0.0 %) | 0(0.0 %) | 0.039* |